Riverview Trust Company’s Insmed INSM Stock Holding History

Riverview Trust Company’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6	Closed	-$438	–	869
2024 Q3	$438	Buy	+6	New	+$443	﹤0.01%	810

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Riverview Trust Company's INSM Position: Q4 2024 in Review

Riverview Trust Company sold out of Insmed (INSM) in Q4 2024, closing a stake of 6 shares — an estimated $438 sold.

Riverview Trust Company first reported a position in INSM in Q3 2024 and held it in 1 quarter. The position peaked at $438 in Q3 2024. 438 funds tracked by Wall St. Rank hold INSM as of Q4 2024.

Riverview Trust Company reported no remaining Insmed position as of Q4 2024 after selling out during the quarter.
Riverview Trust Company sold 6 Insmed shares in Q4 2024, an estimated $438.
Riverview Trust Company first reported a position in Insmed in Q3 2024 and held it in 1 quarter.
Riverview Trust Company's Insmed position peaked at $438 in Q3 2024.
438 funds tracked by Wall St. Rank held Insmed as of Q4 2024.

Based on Riverview Trust Company's 13F filing for Q4 2024, filed 6 Feb 2025.